Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Eisai Inc

+1 (201) 692-1100
Website

Advertisement

Advertisement

300 Technology Sq
Cambridge, MA 02139
+1 (201) 692-1100
https://us.eisai.com

Eisai Inc. is a researched-based human health care company headquartered in Cambridge, dedicated to discovering, developing, and marketing products globally.

With a focus on improving human health, Eisai Inc. is committed to advancing medical innovation and providing valuable solutions to patients worldwide.

Generated from their website's infomation

Also at this address

eGenesis

Iain James Webb, MD - Radius Inc

Myeloid Therapeutics Securities Corp

Kymera Therapeutics

Own this business?
Claim it
See a problem?

You might also like

Drugs acting on the respiratory system, Drugs and drug proprietaries

Aegerion Pharmaceuticals, Inc

Aegerion Pharmaceuticals, Inc is a biopharmaceutical company based in Cambridge, MA. Specializing in the development and commercialization of innovative therapies for rare diseases, the company focuses on addressing unmet medical needs in niche patient populations. With a commitment to research and development, Aegerion Pharmaceuticals, Inc strives to improve the lives of individuals living with rare diseases through the advancement of novel treatment options. By collaborating with healthcare professionals and patients, the company aims to make a meaningful impact in the field of rare disease management. Generated from their business information
Sizes, Drugs acting on the respiratory system, Business services, nec, nec

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
Feathers and feather products, Drugs acting on the respiratory system, Drugs and drug proprietaries

Constellation Pharmaceuticals

Constellation Pharmaceuticals is a biopharmaceutical company based in Cambridge, MA, specializing in the development of novel cancer therapies. The company focuses on targeting epigenetic pathways to discover and advance potential treatments for various types of cancer. Utilizing cutting-edge research and technology, Constellation Pharmaceuticals is dedicated to advancing the field of oncology through innovative drug discovery and development. The company's mission is to improve patient outcomes and make a meaningful impact in the fight against cancer. Generated from their business information
United States›Massachusetts›Cambridge›Eisai Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell